TG Therapeutics, Inc. (TGTX)

TG Therapeutics Market Cap

TG Therapeutics has a market cap or net worth of $7.59 billion as of July 1, 2026. Its market cap has increased by 34.10% in one year.

• Market Cap: 7.59B
• Enterprise Value: 7.82B
• 1-Year Change: 34.10%
• Ranking: #1119
• Category: Mid-Cap
• Stock Price: $53.52

Market Cap Chart

Since December 1, 1998, TG Therapeutics's market cap has increased from $34.90M to $7.59B, an increase of 21,633.57%. That is a compound annual growth rate of 21.53%.

Market Cap History

Date	Market Cap	% Change
Jul 1, 2026	8.19B	73.12%
Dec 31, 2025	4.73B	1.01%
Dec 31, 2024	4.69B	81.18%
Dec 29, 2023	2.59B	50.41%
Dec 30, 2022	1.72B	-36.69%
Dec 31, 2021	2.72B	-60.29%
Dec 31, 2020	6.84B	518.96%
Dec 31, 2019	1.11B	225.13%
Dec 31, 2018	339.90M	-41.33%
Dec 29, 2017	579.30M	127.62%
Dec 30, 2016	254.50M	-59.38%
Dec 31, 2015	626.60M	-10.02%
Dec 31, 2014	696.40M	433.23%
Dec 31, 2013	130.60M	43.20%
Dec 31, 2012	91.20M	91,100.00%
Dec 30, 2011	100.00K	-95.45%
Dec 31, 2010	2.20M	-58.49%
Dec 31, 2009	5.30M	783.33%
Dec 31, 2008	600.00K	-90.63%
Dec 31, 2007	6.40M	-86.18%
Dec 29, 2006	46.30M	-38.35%
Dec 30, 2005	75.10M	181.27%
Dec 31, 2004	26.70M	-27.64%
Dec 31, 2003	36.90M	623.53%
Dec 31, 2002	5.10M	-49.50%

View and export this data all the way back to 1998. Sign Up Today.

Data Source: Nasdaq Data Link Last updated: Jul 1, 2026

Market cap data is provided by Nasdaq Data Link. The current market cap updates continuously throughout the trading day, while the historical market cap is updated daily after market close.

Update frequency:

Daily

Last checked:

Jul 2, 2026

Data Sources Report a data error

Related Stocks

Company	Market Cap
Halozyme Therapeutics	9.28B
ImmunityBio	9.17B
Vaxcyte	8.39B
Immunovant	7.91B
Protagonist Therapeutics	7.88B
Spyre Therapeutics	7.71B
Rhythm Pharmaceuticals	7.61B
Mirum Pharmaceuticals	7.14B